|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102.38 USD | +1.13% |
|
+5.83% | +3.65% |
| 11:09am | Incyte nears up to $2 billion deal for blood disorder biotech Star, FT reports | RE |
| 06-04 | Incyte, Mirum Pharmaceuticals to Present New Zilurgisertib Study Results at Conference | MT |
Official Publications
| 02-09 | SEC Filing 8K | CO |
| 02-09 | Slide show results | CO |
| 02-09 | Annual results | CO |
| 02-09 | SEC Filing 10K | CO |
| 27/10/25 | SEC Filing 8K | CO |
| 27/10/25 | SEC Filing 10Q-3 | CO |
| 27/10/25 | Slide show Q3 | CO |
| 27/10/25 | 3rd quarter results | CO |
| 28/07/25 | SEC Filing 8K | CO |
| 28/07/25 | SEC Filing 10Q-2 | CO |
| 28/07/25 | Slide show half-year results | CO |
| 28/07/25 | 1st-half-year results | CO |
| 09/06/25 | Shareholders meeting voting results | CO |
| 28/04/25 | Slide show Q1 | CO |
| 28/04/25 | SEC Filing 8K | CO |
| 28/04/25 | SEC Filing 10Q-1 | CO |
| 28/04/25 | 1st quarter results | CO |
| 28/04/25 | Proxy Statments | CO |
| 09/02/25 | SEC Filing 10K | CO |
| 09/02/25 | SEC Filing 8K | CO |
| 09/02/25 | Slide show results | CO |
| 09/02/25 | Annual results | CO |
| 05/01/25 | SEC Filing 8K | CO |
| 28/10/24 | SEC Filing 8K | CO |
| 28/10/24 | SEC Filing 10Q-3 | CO |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation
- Official Publications
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















